Keyphrases
Immune Checkpoint Blockade
100%
KDM5A
100%
Combination Therapy
28%
Tumor
28%
Programmed Death-ligand 1 (PD-L1)
28%
Checkpoint Blockade Agents
28%
Signaling Pathway
14%
Cell-Associated
14%
Melanoma
14%
Toll-like
14%
Phosphatase
14%
Histone H3
14%
Mouse Tumor Model
14%
AKT1
14%
Gene Signature
14%
Combination Treatment
14%
Lysine
14%
Immune Checkpoint Therapy
14%
Tumor-associated
14%
Multiple Cancers
14%
Orthogonal Mechanism
14%
Murine Tumor Model
14%
Anti-PD-1 Immunotherapy
14%
Long-term Benefit
14%
S6 Kinase 1 (S6K1)
14%
Demethylase
14%
M1 Macrophages
14%
Bifunctional Reagents
14%
Response Marker
14%
T Cell Activation
14%
Anti-PD-1 Antibody
14%
T Cell Expansion
14%
CD8+ T Cells
14%
Tumor-infiltrating Dendritic Cells
14%
CD103
14%
Tensin Homolog
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Combination Therapy
50%
Cancer Model
50%
Mouse
25%
Immunotherapy
25%
Melanoma
25%
Lysine
25%
CD8 Antigen
25%
Programmed Cell Death
25%
Histone H3
25%
Multiple Cancer
25%
Toll Like Receptor 7
25%
Toll Like Receptor 8
25%
Programmed Death 1 Receptor
25%
Phosphatase
25%
Tensin
25%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
100%
Cell Death
33%
T Cell
33%
Signal Transduction
16%
Mouse
16%
Toll-Like Receptor
16%
Histone H3
16%
Gene Signature
16%
Macrophage
16%
Synapsin I
16%
Lysine
16%
Cell Activation
16%
CD8
16%
PTEN (Gene)
16%
Phosphatase
16%
Cell Expansion
16%
Dendritic Cell
16%
Demethylase
16%
Tensin
16%
Immunology and Microbiology
Immune Checkpoint Blockade
100%
Signal Transduction
16%
Mouse
16%
Macrophage
16%
Cell Death
16%
Immunotherapy
16%
Toll-Like Receptor
16%
Dendritic Cell
16%
Cell Expansion
16%
Cytotoxic T-Cell
16%
Programmed Death 1 Receptor
16%
T Cell Activation
16%